跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 577 条关于
“MAESTRO”
全部
577
临床试验
516
药物
1
机构
14
资讯
46
去年
Moon Surgical Secures FDA Clearance for AI-Powered ScoPilot on Maestro System
2年前
Madrigal's Resmetirom Nears Full Approval for NASH Cirrhosis Treatment Following Phase 3 Enrollment Completion
去年
Madrigal Pharmaceuticals Initiates FDA Submission for NASH Treatment Resmetirom
去年
Madrigal's Rezdiffra Shows Promise in MASH Cirrhosis with Two-Year Data
去年
Resmetirom Shows Promise in Treating MASLD/MASH: A Comprehensive Review of Clinical Trials
3个月前
Rezdiffra Demonstrates Cardiovascular and Liver Risk Reduction in MASH Patients
去年
Rezdiffra Demonstrates Improved Quality of Life in NASH Patients with Fibrosis
2年前
FDA Approves Rezdiffra (Resmetirom) as First Treatment for NASH with Liver Fibrosis
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Provides Corporate Updates
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Clinical Progress in NASH/MASH
第 1 页,共 5 页
上一页
下一页